KAYLA CANTEEN: Open Payments
NPI 1740937580 · MYRTLE BEACH, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$713 in 44 payments from 15 companies in 2025. Trend: 2023 $1,831 · 2024 $2,033 · 2025 $713
Food & beverage: $713
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $236 |
| PFIZER INC. | 5 | $91 |
| Novo Nordisk Inc | 3 | $66 |
| Corcept Therapeutics | 3 | $57 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $39 |
| Abbott Laboratories | 2 | $36 |
| GlaxoSmithKline, LLC. | 2 | $35 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| Otsuka America Pharmaceutical, Inc. | 1 | $29 |
| IRONWOOD PHARMACEUTICALS, INC | 1 | $19 |
Products named: VRAYLAR, UBRELVY, NURTEC ODT, Korlym, Ozempic, TRINTELLIX, QULIPTA, FREESTYLE LIBRE 3.
Industry payments across SC — which companies pay providers there.
